The global Desynchronosis Treatment market is projected to grow from US$ 512 million in 2024 to US$ 690.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period.

Desynchronosis Treatment Market

Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Desynchronosis Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Desynchronosis Treatment, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Desynchronosis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Desynchronosis Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Desynchronosis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Desynchronosis Treatment sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Desynchronosis Treatment Market Report

Report Metric	Details
Report Name	Desynchronosis Treatment Market
Accounted market size in 2024	US$ 512 million
Forecasted market size in 2030	US$ 690.1 million
CAGR	5.1
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Prescription Drugs OTC
Segment by Application	Hospital Pharmacies Retail Pharmacies Online
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan, Clinigen Group, Vanda Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Desynchronosis Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Desynchronosis Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Desynchronosis Treatment sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Desynchronosis Treatment Market growing?

Ans: The Desynchronosis Treatment Market witnessing a CAGR of 5.1 during the forecast period 2025-2030.

What is the Desynchronosis Treatment Market size in 2030?

Ans: The Desynchronosis Treatment Market size in 2030 will be US$ 690.1 million.

Who are the main players in the Desynchronosis Treatment Market report?

Ans: The main players in the Desynchronosis Treatment Market are Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan, Clinigen Group, Vanda Pharma

What are the Application segmentation covered in the Desynchronosis Treatment Market report?

Ans: The Applications covered in the Desynchronosis Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Online

What are the Type segmentation covered in the Desynchronosis Treatment Market report?

Ans: The Types covered in the Desynchronosis Treatment Market report are Prescription Drugs, OTC

1 Study Coverage

1.1 Desynchronosis Treatment Product Introduction

1.2 Market by Type

1.2.1 Global Desynchronosis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Prescription Drugs

1.2.3 OTC

1.3 Market by Application

1.3.1 Global Desynchronosis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Desynchronosis Treatment Sales Estimates and Forecasts 2019-2030

2.2 Global Desynchronosis Treatment Revenue by Region

2.2.1 Global Desynchronosis Treatment Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Desynchronosis Treatment Revenue by Region (2019-2024)

2.2.3 Global Desynchronosis Treatment Revenue by Region (2025-2030)

2.2.4 Global Desynchronosis Treatment Revenue Market Share by Region (2019-2030)

2.3 Global Desynchronosis Treatment Sales Estimates and Forecasts 2019-2030

2.4 Global Desynchronosis Treatment Sales by Region

2.4.1 Global Desynchronosis Treatment Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Desynchronosis Treatment Sales by Region (2019-2024)

2.4.3 Global Desynchronosis Treatment Sales by Region (2025-2030)

2.4.4 Global Desynchronosis Treatment Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Desynchronosis Treatment Sales by Manufacturers

3.1.1 Global Desynchronosis Treatment Sales by Manufacturers (2019-2024)

3.1.2 Global Desynchronosis Treatment Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Desynchronosis Treatment in 2023

3.2 Global Desynchronosis Treatment Revenue by Manufacturers

3.2.1 Global Desynchronosis Treatment Revenue by Manufacturers (2019-2024)

3.2.2 Global Desynchronosis Treatment Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Desynchronosis Treatment Revenue in 2023

3.3 Global Key Players of Desynchronosis Treatment, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Desynchronosis Treatment Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Desynchronosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Desynchronosis Treatment, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Desynchronosis Treatment, Product Offered and Application

3.8 Global Key Manufacturers of Desynchronosis Treatment, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Desynchronosis Treatment Sales by Type

4.1.1 Global Desynchronosis Treatment Historical Sales by Type (2019-2024)

4.1.2 Global Desynchronosis Treatment Forecasted Sales by Type (2025-2030)

4.1.3 Global Desynchronosis Treatment Sales Market Share by Type (2019-2030)

4.2 Global Desynchronosis Treatment Revenue by Type

4.2.1 Global Desynchronosis Treatment Historical Revenue by Type (2019-2024)

4.2.2 Global Desynchronosis Treatment Forecasted Revenue by Type (2025-2030)

4.2.3 Global Desynchronosis Treatment Revenue Market Share by Type (2019-2030)

4.3 Global Desynchronosis Treatment Price by Type

4.3.1 Global Desynchronosis Treatment Price by Type (2019-2024)

4.3.2 Global Desynchronosis Treatment Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Desynchronosis Treatment Sales by Application

5.1.1 Global Desynchronosis Treatment Historical Sales by Application (2019-2024)

5.1.2 Global Desynchronosis Treatment Forecasted Sales by Application (2025-2030)

5.1.3 Global Desynchronosis Treatment Sales Market Share by Application (2019-2030)

5.2 Global Desynchronosis Treatment Revenue by Application

5.2.1 Global Desynchronosis Treatment Historical Revenue by Application (2019-2024)

5.2.2 Global Desynchronosis Treatment Forecasted Revenue by Application (2025-2030)

5.2.3 Global Desynchronosis Treatment Revenue Market Share by Application (2019-2030)

5.3 Global Desynchronosis Treatment Price by Application

5.3.1 Global Desynchronosis Treatment Price by Application (2019-2024)

5.3.2 Global Desynchronosis Treatment Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Desynchronosis Treatment Market Size by Type

6.1.1 US & Canada Desynchronosis Treatment Sales by Type (2019-2030)

6.1.2 US & Canada Desynchronosis Treatment Revenue by Type (2019-2030)

6.2 US & Canada Desynchronosis Treatment Market Size by Application

6.2.1 US & Canada Desynchronosis Treatment Sales by Application (2019-2030)

6.2.2 US & Canada Desynchronosis Treatment Revenue by Application (2019-2030)

6.3 US & Canada Desynchronosis Treatment Market Size by Country

6.3.1 US & Canada Desynchronosis Treatment Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Desynchronosis Treatment Sales by Country (2019-2030)

6.3.3 US & Canada Desynchronosis Treatment Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Desynchronosis Treatment Market Size by Type

7.1.1 Europe Desynchronosis Treatment Sales by Type (2019-2030)

7.1.2 Europe Desynchronosis Treatment Revenue by Type (2019-2030)

7.2 Europe Desynchronosis Treatment Market Size by Application

7.2.1 Europe Desynchronosis Treatment Sales by Application (2019-2030)

7.2.2 Europe Desynchronosis Treatment Revenue by Application (2019-2030)

7.3 Europe Desynchronosis Treatment Market Size by Country

7.3.1 Europe Desynchronosis Treatment Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Desynchronosis Treatment Sales by Country (2019-2030)

7.3.3 Europe Desynchronosis Treatment Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Desynchronosis Treatment Market Size

8.1.1 China Desynchronosis Treatment Sales (2019-2030)

8.1.2 China Desynchronosis Treatment Revenue (2019-2030)

8.2 China Desynchronosis Treatment Market Size by Application

8.2.1 China Desynchronosis Treatment Sales by Application (2019-2030)

8.2.2 China Desynchronosis Treatment Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Desynchronosis Treatment Market Size by Type

9.1.1 Asia Desynchronosis Treatment Sales by Type (2019-2030)

9.1.2 Asia Desynchronosis Treatment Revenue by Type (2019-2030)

9.2 Asia Desynchronosis Treatment Market Size by Application

9.2.1 Asia Desynchronosis Treatment Sales by Application (2019-2030)

9.2.2 Asia Desynchronosis Treatment Revenue by Application (2019-2030)

9.3 Asia Desynchronosis Treatment Sales by Region

9.3.1 Asia Desynchronosis Treatment Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Desynchronosis Treatment Revenue by Region (2019-2030)

9.3.3 Asia Desynchronosis Treatment Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Desynchronosis Treatment Market Size by Type

10.1.1 Middle East, Africa and Latin America Desynchronosis Treatment Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Desynchronosis Treatment Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Desynchronosis Treatment Market Size by Application

10.2.1 Middle East, Africa and Latin America Desynchronosis Treatment Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Desynchronosis Treatment Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Desynchronosis Treatment Sales by Country

10.3.1 Middle East, Africa and Latin America Desynchronosis Treatment Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Desynchronosis Treatment Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Desynchronosis Treatment Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Teva

11.1.1 Teva Company Information

11.1.2 Teva Overview

11.1.3 Teva Desynchronosis Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Teva Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Teva Recent Developments

11.2 Mylan

11.2.1 Mylan Company Information

11.2.2 Mylan Overview

11.2.3 Mylan Desynchronosis Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Mylan Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Mylan Recent Developments

11.3 Nature’s Bounty

11.3.1 Nature’s Bounty Company Information

11.3.2 Nature’s Bounty Overview

11.3.3 Nature’s Bounty Desynchronosis Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Nature’s Bounty Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Nature’s Bounty Recent Developments

11.4 Otsuka Pharma (Pharmavite)

11.4.1 Otsuka Pharma (Pharmavite) Company Information

11.4.2 Otsuka Pharma (Pharmavite) Overview

11.4.3 Otsuka Pharma (Pharmavite) Desynchronosis Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Otsuka Pharma (Pharmavite) Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Otsuka Pharma (Pharmavite) Recent Developments

11.5 Boiron

11.5.1 Boiron Company Information

11.5.2 Boiron Overview

11.5.3 Boiron Desynchronosis Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Boiron Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Boiron Recent Developments

11.6 Miers Laboratories

11.6.1 Miers Laboratories Company Information

11.6.2 Miers Laboratories Overview

11.6.3 Miers Laboratories Desynchronosis Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Miers Laboratories Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Miers Laboratories Recent Developments

11.7 Genexa

11.7.1 Genexa Company Information

11.7.2 Genexa Overview

11.7.3 Genexa Desynchronosis Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Genexa Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Genexa Recent Developments

11.8 Homeocan

11.8.1 Homeocan Company Information

11.8.2 Homeocan Overview

11.8.3 Homeocan Desynchronosis Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Homeocan Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Homeocan Recent Developments

11.9 Clinigen Group

11.9.1 Clinigen Group Company Information

11.9.2 Clinigen Group Overview

11.9.3 Clinigen Group Desynchronosis Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Clinigen Group Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Clinigen Group Recent Developments

11.10 Vanda Pharma

11.10.1 Vanda Pharma Company Information

11.10.2 Vanda Pharma Overview

11.10.3 Vanda Pharma Desynchronosis Treatment Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Vanda Pharma Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Vanda Pharma Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Desynchronosis Treatment Industry Chain Analysis

12.2 Desynchronosis Treatment Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Desynchronosis Treatment Production Mode & Process

12.4 Desynchronosis Treatment Sales and Marketing

12.4.1 Desynchronosis Treatment Sales Channels

12.4.2 Desynchronosis Treatment Distributors

12.5 Desynchronosis Treatment Customers

13 Market Dynamics

13.1 Desynchronosis Treatment Industry Trends

13.2 Desynchronosis Treatment Market Drivers

13.3 Desynchronosis Treatment Market Challenges

13.4 Desynchronosis Treatment Market Restraints

14 Key Findings in The Global Desynchronosis Treatment Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

TEVA

Mylan NV

Nature's Bounty

Otsuka Pharma (Pharmavite)

List of Tables

Table 1. Global Desynchronosis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Prescription Drugs

Table 3. Major Manufacturers of OTC

Table 4. Global Desynchronosis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Desynchronosis Treatment Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Desynchronosis Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Desynchronosis Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Desynchronosis Treatment Revenue Market Share by Region (2019-2024)

Table 9. Global Desynchronosis Treatment Revenue Market Share by Region (2025-2030)

Table 10. Global Desynchronosis Treatment Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Desynchronosis Treatment Sales by Region (2019-2024) & (K Units)

Table 12. Global Desynchronosis Treatment Sales by Region (2025-2030) & (K Units)

Table 13. Global Desynchronosis Treatment Sales Market Share by Region (2019-2024)

Table 14. Global Desynchronosis Treatment Sales Market Share by Region (2025-2030)

Table 15. Global Desynchronosis Treatment Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Desynchronosis Treatment Sales Share by Manufacturers (2019-2024)

Table 17. Global Desynchronosis Treatment Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Desynchronosis Treatment Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Desynchronosis Treatment, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Desynchronosis Treatment Price by Manufacturers 2019-2024 (US$/Unit)

Table 21. Global Desynchronosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Desynchronosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Desynchronosis Treatment as of 2023)

Table 23. Global Key Manufacturers of Desynchronosis Treatment, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Desynchronosis Treatment, Product Offered and Application

Table 25. Global Key Manufacturers of Desynchronosis Treatment, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Desynchronosis Treatment Sales by Type (2019-2024) & (K Units)

Table 28. Global Desynchronosis Treatment Sales by Type (2025-2030) & (K Units)

Table 29. Global Desynchronosis Treatment Sales Share by Type (2019-2024)

Table 30. Global Desynchronosis Treatment Sales Share by Type (2025-2030)

Table 31. Global Desynchronosis Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Desynchronosis Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Desynchronosis Treatment Revenue Share by Type (2019-2024)

Table 34. Global Desynchronosis Treatment Revenue Share by Type (2025-2030)

Table 35. Desynchronosis Treatment Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Desynchronosis Treatment Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Desynchronosis Treatment Sales by Application (2019-2024) & (K Units)

Table 38. Global Desynchronosis Treatment Sales by Application (2025-2030) & (K Units)

Table 39. Global Desynchronosis Treatment Sales Share by Application (2019-2024)

Table 40. Global Desynchronosis Treatment Sales Share by Application (2025-2030)

Table 41. Global Desynchronosis Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Desynchronosis Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Desynchronosis Treatment Revenue Share by Application (2019-2024)

Table 44. Global Desynchronosis Treatment Revenue Share by Application (2025-2030)

Table 45. Desynchronosis Treatment Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Desynchronosis Treatment Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Desynchronosis Treatment Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Desynchronosis Treatment Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Desynchronosis Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Desynchronosis Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Desynchronosis Treatment Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Desynchronosis Treatment Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Desynchronosis Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Desynchronosis Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Desynchronosis Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Desynchronosis Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Desynchronosis Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Desynchronosis Treatment Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Desynchronosis Treatment Sales by Country (2025-2030) & (K Units)

Table 60. Europe Desynchronosis Treatment Sales by Type (2019-2024) & (K Units)

Table 61. Europe Desynchronosis Treatment Sales by Type (2025-2030) & (K Units)

Table 62. Europe Desynchronosis Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Desynchronosis Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Desynchronosis Treatment Sales by Application (2019-2024) & (K Units)

Table 65. Europe Desynchronosis Treatment Sales by Application (2025-2030) & (K Units)

Table 66. Europe Desynchronosis Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Desynchronosis Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Desynchronosis Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Desynchronosis Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Desynchronosis Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Desynchronosis Treatment Sales by Country (2019-2024) & (K Units)

Table 72. Europe Desynchronosis Treatment Sales by Country (2025-2030) & (K Units)

Table 73. China Desynchronosis Treatment Sales by Type (2019-2024) & (K Units)

Table 74. China Desynchronosis Treatment Sales by Type (2025-2030) & (K Units)

Table 75. China Desynchronosis Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Desynchronosis Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Desynchronosis Treatment Sales by Application (2019-2024) & (K Units)

Table 78. China Desynchronosis Treatment Sales by Application (2025-2030) & (K Units)

Table 79. China Desynchronosis Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Desynchronosis Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Desynchronosis Treatment Sales by Type (2019-2024) & (K Units)

Table 82. Asia Desynchronosis Treatment Sales by Type (2025-2030) & (K Units)

Table 83. Asia Desynchronosis Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Desynchronosis Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Desynchronosis Treatment Sales by Application (2019-2024) & (K Units)

Table 86. Asia Desynchronosis Treatment Sales by Application (2025-2030) & (K Units)

Table 87. Asia Desynchronosis Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Desynchronosis Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Desynchronosis Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Desynchronosis Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Desynchronosis Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Desynchronosis Treatment Sales by Region (2019-2024) & (K Units)

Table 93. Asia Desynchronosis Treatment Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Desynchronosis Treatment Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Desynchronosis Treatment Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Desynchronosis Treatment Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Desynchronosis Treatment Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Desynchronosis Treatment Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Desynchronosis Treatment Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Desynchronosis Treatment Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Desynchronosis Treatment Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Desynchronosis Treatment Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Desynchronosis Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Desynchronosis Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Desynchronosis Treatment Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Desynchronosis Treatment Sales by Country (2025-2030) & (K Units)

Table 107. Teva Company Information

Table 108. Teva Description and Major Businesses

Table 109. Teva Desynchronosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Teva Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Teva Recent Developments

Table 112. Mylan Company Information

Table 113. Mylan Description and Major Businesses

Table 114. Mylan Desynchronosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Mylan Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Mylan Recent Developments

Table 117. Nature’s Bounty Company Information

Table 118. Nature’s Bounty Description and Major Businesses

Table 119. Nature’s Bounty Desynchronosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Nature’s Bounty Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Nature’s Bounty Recent Developments

Table 122. Otsuka Pharma (Pharmavite) Company Information

Table 123. Otsuka Pharma (Pharmavite) Description and Major Businesses

Table 124. Otsuka Pharma (Pharmavite) Desynchronosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Otsuka Pharma (Pharmavite) Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Otsuka Pharma (Pharmavite) Recent Developments

Table 127. Boiron Company Information

Table 128. Boiron Description and Major Businesses

Table 129. Boiron Desynchronosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Boiron Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Boiron Recent Developments

Table 132. Miers Laboratories Company Information

Table 133. Miers Laboratories Description and Major Businesses

Table 134. Miers Laboratories Desynchronosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Miers Laboratories Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Miers Laboratories Recent Developments

Table 137. Genexa Company Information

Table 138. Genexa Description and Major Businesses

Table 139. Genexa Desynchronosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. Genexa Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Genexa Recent Developments

Table 142. Homeocan Company Information

Table 143. Homeocan Description and Major Businesses

Table 144. Homeocan Desynchronosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 145. Homeocan Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Homeocan Recent Developments

Table 147. Clinigen Group Company Information

Table 148. Clinigen Group Description and Major Businesses

Table 149. Clinigen Group Desynchronosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 150. Clinigen Group Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Clinigen Group Recent Developments

Table 152. Vanda Pharma Company Information

Table 153. Vanda Pharma Description and Major Businesses

Table 154. Vanda Pharma Desynchronosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 155. Vanda Pharma Desynchronosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Vanda Pharma Recent Developments

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Desynchronosis Treatment Distributors List

Table 160. Desynchronosis Treatment Customers List

Table 161. Desynchronosis Treatment Market Trends

Table 162. Desynchronosis Treatment Market Drivers

Table 163. Desynchronosis Treatment Market Challenges

Table 164. Desynchronosis Treatment Market Restraints

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

List of Figures

Figure 1. Desynchronosis Treatment Product Picture

Figure 2. Global Desynchronosis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Desynchronosis Treatment Market Share by Type in 2023 & 2030

Figure 4. Prescription Drugs Product Picture

Figure 5. OTC Product Picture

Figure 6. Global Desynchronosis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Desynchronosis Treatment Market Share by Application in 2023 & 2030

Figure 8. Hospital Pharmacies

Figure 9. Retail Pharmacies

Figure 10. Online

Figure 11. Desynchronosis Treatment Report Years Considered

Figure 12. Global Desynchronosis Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Desynchronosis Treatment Revenue 2019-2030 (US$ Million)

Figure 14. Global Desynchronosis Treatment Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Desynchronosis Treatment Revenue Market Share by Region (2019-2030)

Figure 16. Global Desynchronosis Treatment Sales 2019-2030 ((K Units)

Figure 17. Global Desynchronosis Treatment Sales Market Share by Region (2019-2030)

Figure 18. US & Canada Desynchronosis Treatment Sales YoY (2019-2030) & (K Units)

Figure 19. US & Canada Desynchronosis Treatment Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Desynchronosis Treatment Sales YoY (2019-2030) & (K Units)

Figure 21. Europe Desynchronosis Treatment Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Desynchronosis Treatment Sales YoY (2019-2030) & (K Units)

Figure 23. China Desynchronosis Treatment Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Asia (excluding China) Desynchronosis Treatment Sales YoY (2019-2030) & (K Units)

Figure 25. Asia (excluding China) Desynchronosis Treatment Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Desynchronosis Treatment Sales YoY (2019-2030) & (K Units)

Figure 27. Middle East, Africa and Latin America Desynchronosis Treatment Revenue YoY (2019-2030) & (US$ Million)

Figure 28. The Desynchronosis Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 29. The Top 5 and 10 Largest Manufacturers of Desynchronosis Treatment in the World: Market Share by Desynchronosis Treatment Revenue in 2023

Figure 30. Global Desynchronosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 31. Global Desynchronosis Treatment Sales Market Share by Type (2019-2030)

Figure 32. Global Desynchronosis Treatment Revenue Market Share by Type (2019-2030)

Figure 33. Global Desynchronosis Treatment Sales Market Share by Application (2019-2030)

Figure 34. Global Desynchronosis Treatment Revenue Market Share by Application (2019-2030)

Figure 35. US & Canada Desynchronosis Treatment Sales Market Share by Type (2019-2030)

Figure 36. US & Canada Desynchronosis Treatment Revenue Market Share by Type (2019-2030)

Figure 37. US & Canada Desynchronosis Treatment Sales Market Share by Application (2019-2030)

Figure 38. US & Canada Desynchronosis Treatment Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Desynchronosis Treatment Revenue Share by Country (2019-2030)

Figure 40. US & Canada Desynchronosis Treatment Sales Share by Country (2019-2030)

Figure 41. U.S. Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 42. Canada Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 43. Europe Desynchronosis Treatment Sales Market Share by Type (2019-2030)

Figure 44. Europe Desynchronosis Treatment Revenue Market Share by Type (2019-2030)

Figure 45. Europe Desynchronosis Treatment Sales Market Share by Application (2019-2030)

Figure 46. Europe Desynchronosis Treatment Revenue Market Share by Application (2019-2030)

Figure 47. Europe Desynchronosis Treatment Revenue Share by Country (2019-2030)

Figure 48. Europe Desynchronosis Treatment Sales Share by Country (2019-2030)

Figure 49. Germany Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 50. France Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 51. U.K. Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 52. Italy Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 53. Russia Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 54. China Desynchronosis Treatment Sales Market Share by Type (2019-2030)

Figure 55. China Desynchronosis Treatment Revenue Market Share by Type (2019-2030)

Figure 56. China Desynchronosis Treatment Sales Market Share by Application (2019-2030)

Figure 57. China Desynchronosis Treatment Revenue Market Share by Application (2019-2030)

Figure 58. Asia Desynchronosis Treatment Sales Market Share by Type (2019-2030)

Figure 59. Asia Desynchronosis Treatment Revenue Market Share by Type (2019-2030)

Figure 60. Asia Desynchronosis Treatment Sales Market Share by Application (2019-2030)

Figure 61. Asia Desynchronosis Treatment Revenue Market Share by Application (2019-2030)

Figure 62. Asia Desynchronosis Treatment Revenue Share by Region (2019-2030)

Figure 63. Asia Desynchronosis Treatment Sales Share by Region (2019-2030)

Figure 64. Japan Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 65. South Korea Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 66. China Taiwan Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 67. Southeast Asia Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 68. India Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 69. Middle East, Africa and Latin America Desynchronosis Treatment Sales Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Desynchronosis Treatment Revenue Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Desynchronosis Treatment Sales Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Desynchronosis Treatment Revenue Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Desynchronosis Treatment Revenue Share by Country (2019-2030)

Figure 74. Middle East, Africa and Latin America Desynchronosis Treatment Sales Share by Country (2019-2030)

Figure 75. Brazil Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 76. Mexico Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 77. Turkey Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 78. Israel Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 79. GCC Countries Desynchronosis Treatment Revenue (2019-2030) & (US$ Million)

Figure 80. Desynchronosis Treatment Value Chain

Figure 81. Desynchronosis Treatment Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Jet Lag Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Jet Lag Treatment Market Insights Forecast to 2030

Global Jet Lag Therapy Pharmaceuticals Market Insights Forecast to 2030

Global Jet Lag Therapy APP Market Insights Forecast to 2030

Global Jet Lag Therapy Device Market Insights Forecast to 2030

Global Circadian Rhythm Sleep Treatment Market Research Report 2025

Global Circadian Rhythm Sleep Disorders Market Insights Forecast to 2030

Global Jet Lag Therapy Market Research Report 2024

Global Airsickness Treatment Market Insights Forecast to 2030

Global Travel Sickness Drugs Market Insights Forecast to 2030

Global Anticholinergic Travel Sickness Drugs Market Insights Forecast to 2030

Global Seasickness Medicine Market Insights Forecast to 2030

Global Antihistamines Travel Sickness Drugs Market Insights Forecast to 2030

Global Motion Sickness Durg Market Insights Forecast to 2030

Global Hypersomnia Drug Market Insights Forecast to 2030

Non 24 hour Sleep wake Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Motion Sickness Pills Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Fatigue Syndrome Treatment Market Insights Forecast to 2030

Short Sleep Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Gastric Mucosal Protective Drug Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26U19007

Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Anesthetic Gas Purification and Recovery Device Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37Q15545

Fri May 16 00:00:00 UTC 2025

Add to Cart

Global Beating Heart Stabilizer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2R15767

Fri May 16 00:00:00 UTC 2025

Add to Cart

Global Bipolar Disorder Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Z15903

Fri May 16 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions